Time‐scored functional assessments of muscle performance · people with myotonic dystrophy
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Quality of life · people with myotonic dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain · people with myotonic dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue · people with myotonic dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · people with myotonic dystrophy
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Muscle strength · people with facioscapulohumeral muscular dystrophy
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Aerobic capacity · people with facioscapulohumeral muscular dystrophy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
ALS Functional Rating Scale (ALSFRS) score at 3 months Scale from: 0 to 40 (higher is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Short‐Form‐36 Health Survey (SF‐36) score at 3 months Scale from: 0 to 100 (higher is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Fatigue Severity Scale score at 3 months Scale from: 0 to 63 (lower is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Manual Muscle Testing score at 3 months Right and left shoulder abduction, elbow flexion and extension, finger abduction and extension, hip flexion, knee flexion and extension, foot dorsiflexion and plantarflexion assessed and graded 0 to 5 Medica... · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Upper extremity maximum voluntary isometric contraction score at 3 months Quantitative Muscle Assessment (QMA) system. Data were normalized, summed and averaged to yield an U/E megascore (higher is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Lower extremity maximum voluntary isometric contraction score at 3 months Quantitative Muscle Assessment (QMA) system. Data were normalized, summed and averaged to yield a L/E megascore (higher is better). · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
Adverse effects related to the intervention · people with amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Short‐term overall improvement (three months or less) · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
It is very uncertain whether neurodynamic mobilisation changes short‐term overall improvement (three months or less) compared with no treatment (very low certainty).
1 finding from 1 review
Adverse effects · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
Short‐term improvement in CTS symptoms (pain) (3 months or less) ‐ At end of 12 weeks treatment (Protouch Keyboard) Scale: 0 to 10 · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
Short‐term improvement in functional ability or health‐related quality of life (hand function) (three months or less) · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
It is very uncertain whether neurodynamic mobilisation changes short‐term improvement in functional ability or health‐related… compared with no treatment (very low certainty).
1 finding from 1 review
Improvement in neurophysiological parameters at ≤ 3 months · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review
CTS symptoms (Boston CTS questionnaire) ‐ long‐term improvement: > 3 monthsScale: 1 to 5, higher is worse · People with carpal tunnel syndrome on a waiting list for carpal tunnel release
1 finding from 1 review